-
-
-
-
-
-
-
Needham Downgrades Amphastar Pharmaceuticals (AMPH) to Hold
-
-
-
-
-
-
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $30 at Needham
-
-
-
-
-
-
-
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
-
-
-
-
-
-
-
Amphastar enters $2.8 million research agreement with Hanxin
-
-
-
-
-
-
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $25 at Piper Sandler
-
-
-
-
-
-
-
JPMorgan Downgrades Amphastar Pharmaceuticals (AMPH) to Neutral
-
-
-
-
-
-
-
Amphastar Pharmaceuticals (AMPH) PT Lowered to $32 at Piper Sandler; 'A Tough 2025 Ahead'
-
443,884 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

